Clinical trial shows gene editing works for β-Thalassaemia, too

Ars TechnicaArs Technica
April 9, 2026 at 08:28 PM
Clinical trial shows gene editing works for β-Thalassaemia, too

Improved gene editing process reactivates the fetal version of a hemoglobin gene.